<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">HCV </span>
   <span class="font25">patients </span>
   <span class="font20">acute </span>
   <span class="font18">KR, </span>
   <span class="font17">infection </span>
   <span class="font17">chronic </span>
   <span class="font16">transmission </span>
   <span class="font16">NSA </span>
   <span class="font15">VI, </span>
   <span class="font15">Acute </span>
   <span class="font14">ST, </span>
   <span class="font14">LV, </span>
   <span class="font14">using </span>
   <span class="font14">VA, </span>
   <span class="font14">VT, </span>
   <span class="font14">virus </span>
   <span class="font13">hepatitis </span>
   <span class="font13">[]. </span>
   <span class="font13">AS, </span>
   <span class="font13">LF, </span>
   <span class="font13">cluster </span>
   <span class="font13">infected </span>
   <span class="font12">(–aa) </span>
   <span class="font12">Chronic </span>
   <span class="font12">clusters </span>
   <span class="font12">{border-style </span>
   <span class="font12">observed </span>
   <span class="font12">TS, </span>
   <span class="font12">px;} </span>
   <span class="font12">sequences </span>
   <span class="font12">sequencing </span>
   <span class="font12">viral </span>
   <span class="font12">β-thalassemia </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">NGS </span>
   <span class="font12">SA, </span>
   <span class="font12">analysis </span>
   <span class="font12">involved </span>
   <span class="font12">prevalence </span>
   <span class="font12">resistance </span>
   <span class="font12">Sanger </span>
   <span class="font12">higher </span>
   <span class="font12">patient </span>
   <span class="font12">variants </span>
   <span class="font12">onco-hematologic </span>
   <span class="font12">phylogenetic </span>
   <span class="font12">sequence </span>
   <span class="font12">variability </span>
   <span class="font12">Hepatitis </span>
   <span class="font12">QH, </span>
   <span class="font12">patients, </span>
   <span class="font12">showed </span>
   <span class="font11">median </span>
   <span class="font11">NS, </span>
   <span class="font11">Shannon </span>
   <span class="font11">[IQR </span>
   <span class="font11">cutoff </span>
   <span class="font11">disease </span>
   <span class="font11">AT, </span>
   <span class="font11">QL, </span>
   <span class="font11">RQ, </span>
   <span class="font11">individuals </span>
   <span class="font11">infection, </span>
   <span class="font11">infection. </span>
   <span class="font11">nosocomial </span>
   <span class="font11">nucleotide </span>
   <span class="font11">AG, </span>
   <span class="font11">Bayesian </span>
   <span class="font11">PQ, </span>
   <span class="font11">Patients </span>
   <span class="font11">RK, </span>
   <span class="font11">TA, </span>
   <span class="font11">TM, </span>
   <span class="font11">[], </span>
   <span class="font11">diagnosis </span>
   <span class="font11">intra-host </span>
   <span class="font11">KA, </span>
   <span class="font11">TN, </span>
   <span class="font11">associated </span>
   <span class="font11">different </span>
   <span class="font11">identified </span>
   <span class="font11">minority </span>
   <span class="font11">patterns </span>
   <span class="font11">study </span>
   <span class="font11">FS, </span>
   <span class="font11">FY, </span>
   <span class="font11">NSB </span>
   <span class="font11">Table </span>
   <span class="font11">common </span>
   <span class="font11">cutoffs </span>
   <span class="font11">gene </span>
   <span class="font11">genotype </span>
   <span class="font11">intra-patient </span>
   <span class="font11">online: </span>
   <span class="font11">performed </span>
   <span class="font11">present </span>
   <span class="font11">px; </span>
   <span class="font11">tree </span>
   <span class="font11">{font-family </span>
   <span class="font11">HCV-RNA </span>
   <span class="font11">KQ, </span>
   <span class="font11">NR, </span>
   <span class="font11">QE, </span>
   <span class="font11">RN, </span>
   <span class="font11">TI, </span>
   <span class="font11">Transmission </span>
   <span class="font11">according </span>
   <span class="font11">analysed </span>
   <span class="font11">font-size </span>
   <span class="font11">genotypes </span>
   <span class="font11">mutations </span>
   <span class="font11">number </span>
   <span class="font11">quasispecies </span>
   <span class="font11">resistant </span>
   <span class="font11">used </span>
   <span class="font11">values </span>
   <span class="font10">.–.] </span>
   <span class="font10">Common </span>
   <span class="font10">DAA </span>
   <span class="font10">GEG, </span>
   <span class="font10">HR, </span>
   <span class="font10">IL-B </span>
   <span class="font10">Italian </span>
   <span class="font10">ML, </span>
   <span class="font10">Median </span>
   <span class="font10">NNS, </span>
   <span class="font10">QK, </span>
   <span class="font10">SN, </span>
   <span class="font10">Virus </span>
   <span class="font10">[,]. </span>
   <span class="font10">cluster. </span>
   <span class="font10">confirmed </span>
   <span class="font10">consensus </span>
   <span class="font10">double; </span>
   <span class="font10">haemodialysis </span>
   <span class="font10">high </span>
   <span class="font10">involving </span>
   <span class="font10">previously </span>
   <span class="font10">reported </span>
   <span class="font10">significant </span>
   <span class="font10">transmitted </span>
   <span class="font10">variant </span>
   <span class="font10">β-thalassemia. </span>
   <span class="font10">(%) </span>
   <span class="font10">(.) </span>
   <span class="font10">(IQR) </span>
   <span class="font10">(Table </span>
   <span class="font10">AV, </span>
   <span class="font10">DNA </span>
   <span class="font10">Figure </span>
   <span class="font10">GK, </span>
   <span class="font10">Genotype </span>
   <span class="font10">Hosp. </span>
   <span class="font10">Infect. </span>
   <span class="font10">Infection </span>
   <span class="font10">KKR, </span>
   <span class="font10">NSV </span>
   <span class="font10">November </span>
   <span class="font10">RKR, </span>
   <span class="font10">SG, </span>
   <span class="font10">Sequences </span>
   <span class="font10">Sequencing </span>
   <span class="font10">TAT, </span>
   <span class="font10">TIT, </span>
   <span class="font10">VGV, </span>
   <span class="font10">VIV, </span>
   <span class="font10">YH, </span>
   <span class="font10">aa) </span>
   <span class="font10">and/or </span>
   <span class="font10">available </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">calculated </span>
   <span class="font10">case </span>
   <span class="font10">cases </span>
   <span class="font10">clinical </span>
   <span class="font10">entropy </span>
   <span class="font10">estimated </span>
   <span class="font10">evidence </span>
   <span class="font10">failed </span>
   <span class="font10">genomic </span>
   <span class="font10">healthcare </span>
   <span class="font10">highest </span>
   <span class="font10">information </span>
   <span class="font10">levels </span>
   <span class="font10">medical </span>
   <span class="font10">method </span>
   <span class="font10">outbreak </span>
   <span class="font10">polymorphism </span>
   <span class="font10">posterior </span>
   <span class="font10">presence </span>
   <span class="font10">probability </span>
   <span class="font10">received </span>
   <span class="font10">respectively. </span>
   <span class="font10">sequencing, </span>
   <span class="font10">seven </span>
   <span class="font10">significantly </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">versus </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">β-thalassemia-patients </span>
   <span class="font10">(.–.) </span>
   <span class="font10">(Illumina </span>
   <span class="font10">(Sn </span>
   <span class="font10">(prevalent </span>
   <span class="font10">.). </span>
   <span class="font10">AAT, </span>
   <span class="font10">Analysis </span>
   <span class="font10">Cluster </span>
   <span class="font10">EA, </span>
   <span class="font10">ED, </span>
   <span class="font10">EQ, </span>
   <span class="font10">Entropy </span>
   <span class="font10">ILB </span>
   <span class="font10">IV, </span>
   <span class="font10">Infect../j.jhin... </span>
   <span class="font10">LM, </span>
   <span class="font10">LQ, </span>
   <span class="font10">MMV, </span>
   <span class="font10">Mutations </span>
   <span class="font10">NGS, </span>
   <span class="font10">Patterns </span>
   <span class="font10">RAS </span>
   <span class="font10">RASs </span>
   <span class="font10">Statistical </span>
   <span class="font10">TMT, </span>
   <span class="font10">TV, </span>
   <span class="font10">VL, </span>
   <span class="font10">YHY </span>
   <span class="font10">[,,]. </span>
   <span class="font10">acid </span>
   <span class="font10">additional </span>
   <span class="font10">based </span>
   <span class="font10">better </span>
   <span class="font10">bold </span>
   <span class="font10">cells---t_Table </span>
   <span class="font10">characterize </span>
   <span class="font10">clearance </span>
   <span class="font10">clusters, </span>
   <span class="font10">clusters. </span>
   <span class="font10">comparison </span>
   <span class="font10">courier; </span>
   <span class="font10">difference </span>
   <span class="font10">distribution </span>
   <span class="font10">drug </span>
   <span class="font10">em; </span>
   <span class="font10">files </span>
   <span class="font10">followed </span>
   <span class="font10">genes </span>
   <span class="font10">genetic </span>
   <span class="font10">human </span>
   <span class="font10">investigate </span>
   <span class="font10">mutation </span>
   <span class="font10">new </span>
   <span class="font10">obtained </span>
   <span class="font10">patient. </span>
   <span class="font10">percentage </span>
   <span class="font10">pt;} </span>
   <span class="font10">serum </span>
   <span class="font10">shared </span>
   <span class="font10">studies </span>
   <span class="font10">study, </span>
   <span class="font10">test </span>
   <span class="font10">tested </span>
   <span class="font10">treatment </span>
   <span class="font10">ultra-deep </span>
  </p>
 </body>
</html>
